Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction.

Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies The OVERCOME Trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies) Xavier Bosch, MD, PHD,*y Montserrat Rovira, MD, PHD,yz Marta Sitges, MD, PHD,*y Ariadna Domènech, RN,z José T. Ortiz-Pérez, MD, PHD,*y Teresa M. de Caralt, MD, PHD,x Manuel Morales-Ruiz, PHD,yk Rosario J. Perea, MD, PHD,x Mariano Monzó, MD, PHD,y{ Jordi Esteve, MD, PHDyz